Order Revolax™ Deep W/ Lidocaine for Clinics

Revolax™ Deep W/ Lidocaine is a sterile, cross-linked hyaluronic acid dermal filler supplied for professional aesthetic use. Licensed clinics and healthcare professionals can order Revolax Deep with Lidocaine 1.1ml as a pre-filled syringe for treatment-room workflows that require cohesive handling and integrated anesthetic support.

This injectable gel is used by trained practitioners for mid-to-deep dermal augmentation and contour refinement. Its single-phase hyaluronic acid matrix is designed for controlled placement, consistent extrusion, and a smooth feel when administered with appropriate professional technique.

Clinic Ordering, Price, and Pack Details

Revolax Deep with Lidocaine price is shown through the clinic ordering account, so purchasing teams can align procurement with current allocation, room usage, and scheduled appointments. The product is supplied as one sterile pre-filled syringe containing 1.1ml, supporting straightforward documentation and lot tracking during intake.

Because this is a professional-use dermal filler, ordering should match the protocols used by your licensed practice. Clinics often plan filler inventory by treatment area, injector preference, rheology profile, and expected appointment volume rather than by a single universal quantity.

Med Wholesale Supplies serves licensed clinics, med spas, and healthcare professionals with brand-name medical products sourced through vetted distributors and verified supply channels. Orders can be coordinated with reliable US logistics, and temperature-controlled handling when required and tracked US delivery may be used to support receiving procedures.

Quick tip: Record lot number, expiration date, and syringe count during receiving so treatment-room documentation stays consistent.

What Revolax Deep with Lidocaine Is

Revolax Deep dermal filler with Lidocaine is a sterile, biodegradable hyaluronic acid gel formulated with an anesthetic component. Hyaluronic acid is a water-binding polysaccharide used in soft-tissue fillers because it can support temporary volume, contour, and tissue hydration within professional aesthetic treatment plans.

The product uses cross-linked, non-animal hyaluronic acid in a cohesive single-phase gel. Cross-linking helps create a stable gel network, while the cohesive structure supports controlled shaping and predictable syringe flow. Lidocaine is included to help reduce injection discomfort during the procedure and may simplify setup compared with using a separate local anesthetic step.

Practitioners commonly evaluate Revolax Deep hyaluronic acid filler by its viscosity, elasticity, extrusion force, and tissue integration profile. These rheology factors help clinical teams decide whether a filler is appropriate for a planned plane, target area, and desired structural effect.

Professional Applications and Treatment-Room Fit

Clinicians use this class of filler for mid-to-deep dermal augmentation within comprehensive facial rejuvenation plans. Typical professional applications include correction of moderate-to-severe facial folds, support for nasolabial and marionette fold work, and contour refinement in areas such as the chin or nose when indicated by assessment and technique.

Revolax Deep injectable filler may be selected when a practitioner wants cohesive placement and measured projection. The gel’s handling profile can be useful where controlled lift, line support, and smooth transition zones are priorities. Final technique, injection depth, volume, and patient selection remain clinical decisions for trained injectors.

For practices standardizing multiple filler protocols, the broader Revolax range can help organize product selection by firmness and intended plane. Teams that require a lighter product for more superficial correction may also assess Revolax Fine with Lidocaine, while deeper structural workflows may involve Revolax SubQ.

Key Features for Licensed Practices

• Pre-filled syringe format: Supplied as Revolax Deep with Lidocaine 1.1ml in one sterile syringe.
• Cross-linked HA gel: Designed to maintain a cohesive structure after placement.
• Non-animal origin: Hyaluronic acid source supports broad compatibility considerations.
• Integrated lidocaine: Included anesthetic helps improve procedural comfort.
• Single-phase matrix: Uniform gel behavior supports controlled contouring.
• Biodegradable material: Gradually resorbs through normal tissue pathways.
• Professional labeling: Lot and expiration information support clinic records.
• Single-use sterility: Intended for one procedure and should not be re-sterilized.
• Consistent extrusion: Smooth syringe flow can help trained injectors place the gel precisely.

Why it matters: A predictable syringe and traceable sterile unit reduce avoidable variation during busy clinic sessions.

Composition and Mechanism

Revolax Deep with Lidocaine syringe contains cross-linked hyaluronic acid, lidocaine, water for injection, and buffering components as described in manufacturer labeling. The HA gel provides temporary tissue support by occupying space and binding water, while the cross-linked network helps the material maintain shape under normal facial movement.

Lidocaine is a local anesthetic included to reduce discomfort during injection. Its presence does not replace clinical judgment around topical anesthesia, nerve blocks, patient sensitivity, or procedural pain management. Clinics should follow their own protocols and the manufacturer’s instructions for use.

The gel is intended for implantation by qualified professionals only. It should not be mixed with other products before implantation, re-sterilized, or used when package integrity is compromised.

Handling, Storage, and Documentation

Maintain the syringe within the manufacturer’s labeled storage conditions until use. Keep the sterile blister and carton intact, and do not use the product if the packaging appears damaged, previously opened, or inconsistent with clinic receiving standards.

At intake, document the product name, lot number, expiration date, syringe quantity, and storage location. These records support internal quality processes, patient charting, and inventory rotation. First-expire, first-out rotation is a practical approach for filler stock rooms and treatment carts.

Before a procedure, staff should verify the intended product against the treatment plan, confirm sterile packaging, and prepare compatible supplies. Clinics may coordinate filler purchasing with adjacent aesthetic supplies through professional sourcing guidance such as wholesale filler sourcing standards.

Safety, Contraindications, and Professional Precautions

Dermal fillers can cause expected local reactions such as swelling, redness, tenderness, bruising, itching, firmness, or temporary discomfort at the injection site. These effects are often procedure-related, but clinics should give patients clear aftercare instructions and escalation guidance according to professional standards.

Serious complications are uncommon but can include infection, nodules, inflammatory reactions, vascular compromise, tissue injury, or visual symptoms if filler is inadvertently injected into or compresses a blood vessel. Practitioners should be trained in facial anatomy, aspiration and injection technique limitations, complication recognition, and appropriate emergency management.

This product should not be used in areas containing implants and should not be mixed with other products before implantation. The existing clinical cautions also note that it is not for individuals with coagulation disorders or recent anticoagulant, thrombolytic, or antiplatelet use. Clinics should assess medical history, active skin disease, allergies, prior filler history, and treatment-area risk before administration.

For wider safety education around filler selection and adverse-event prevention, practices may review Revolax filler safety considerations and regulator guidance such as the FDA dermal fillers information.

How It Compares with Nearby Filler Choices

Revolax Deep is typically considered when a practice wants a cohesive HA gel for moderate-to-deep correction and contour support. It is not automatically better than another filler brand or formulation; the best choice depends on tissue plane, desired firmness, patient anatomy, injector technique, and the practice’s established protocols.

Clinics comparing options often look at HA concentration, cross-linking technology, G prime, viscosity, cohesivity, syringe feel, anesthetic content, and expected tissue behavior. A product with a firmer profile may suit structural work, while a softer gel may be preferred for delicate transitions or more superficial placement.

Related deep-filler choices include Dermalax Deep Plus with Lidocaine, Perfectha Deep Lidocaine, and Renefil Deep Plus. These alternatives can be assessed by trained clinical leads when matching rheology to technique and treatment goals.

Inventory Planning for Aesthetic Practices

For multi-room clinics, Revolax Deep 1.1ml with Lidocaine can be planned as part of a structured HA filler inventory. Keep separate counts for deep, superficial, and volumizing products so injectors can select the correct syringe without disrupting room flow.

Purchasing teams may also review filler education and staff alignment materials, including a practical dermal filler selection guide and guidance on lidocaine in dermal filler procedures. These resources can help standardize language across procurement, clinical training, and patient-facing explanation.

After treatment, outcome assessment should focus on symmetry, contour, tissue response, and patient-specific goals documented by the clinician. Practices that track visual outcomes may find structured evaluation useful; dermal filler before-and-after assessment offers context for evaluating aesthetic changes responsibly.

Authoritative Sources

For additional clinical and regulatory context on soft-tissue fillers, consult the manufacturer’s instructions for use and regulator information. The FDA provides broad safety information for dermal fillers, including potential risks, patient assessment considerations, and complication awareness.

• FDA dermal fillers information

This content is for informational purposes only and is not a substitute for professional medical advice.